NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 119 filers reported holding NURIX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $394 | -5.5% | 50,148 | +20.2% | 0.00% | +33.3% |
| Q2 2023 | $417 | -99.9% | 41,718 | +60.7% | 0.00% | -25.0% |
| Q3 2022 | $338,000 | +60.2% | 25,954 | +72.6% | 0.00% | +33.3% |
| Q1 2022 | $211,000 | -34.5% | 15,034 | +39.9% | 0.00% | -25.0% |
| Q3 2021 | $322,000 | – | 10,747 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 4,508,333 | $140,164,000 | 17.73% |
| Ponoi II Management, LLC | 686,274 | $21,336,000 | 16.34% |
| Column Group LLC | 5,383,333 | $167,368,000 | 16.04% |
| Ponoi Management, LLC | 686,274 | $21,336,000 | 12.55% |
| Foresite Capital Management IV, LLC | 1,238,456 | $38,504,000 | 4.61% |
| Foresite Capital Management V, LLC | 451,522 | $14,038,000 | 4.13% |
| WestHill Financial Advisors, Inc. | 283,333 | $8,809,000 | 3.13% |
| EcoR1 Capital, LLC | 2,019,019 | $62,771,000 | 2.78% |
| Bain Capital Life Sciences Investors, LLC | 1,284,314 | $39,929,000 | 2.26% |
| DAFNA Capital Management LLC | 306,320 | $9,523,000 | 2.26% |